Primary screening of blood donors by nat testing for HCV-RNA: development of an "in-house" method and results

Author:

Wendel Silvano1,Levi José Eduardo1,Takaoka Deise Tihe2,Silva Isabela Cristina2,Castro Juliana Polachini de2,Torezan-Filho Mário A.1,Ghaname Jorge3,Gioachini Romualdo4,Brandão Joselito5,Durigon Edison Luis6

Affiliation:

1. Hospital Sírio Libanês, Brasil; Centro de Imunologia e Imunogenética, Brasil

2. Centro de Imunologia e Imunogenética, Brasil

3. Hospital Nove de Julho, Brasil

4. Hospital Oswaldo Cruz, Brasil; Hospital Evaldo Foz, Brasil

5. Hospital Evaldo Foz, Brasil

6. Universidade de São Paulo, Brasil

Abstract

An "in-house" RT-PCR method was developed that allows the simultaneous detection of the RNA of the Hepatitis C Virus (HCV) and an artificial RNA employed as an external control. Samples were analyzed in pools of 6-12 donations, each donation included in two pools, one horizontal and one vertical, permitting the immediate identification of a reactive donation, obviating the need for pool dismembering. The whole process took 6-8 hours per day and results were issued in parallel to serology. The method was shown to detect all six HCV genotypes and a sensitivity of 500 IU/mL was achieved (95% hit rate). Until July 2005, 139,678 donations were tested and 315 (0.23%) were found reactive for HCV-RNA. Except for five false-positives, all 310 presented the corresponding antibody as well, so the yield of NAT-only donations was zero, presenting a specificity of 99.83%. Detection of a window period donation, in the population studied, will probably demand testing of a larger number of donations. International experience is showing a rate of 1:200,000 - 1:500,000 of isolated HCV-RNA reactive donations.

Publisher

FapUNIFESP (SciELO)

Subject

Infectious Diseases,General Medicine

Reference38 articles.

1. Detection of a healthy carrier of HCV with no evidence of antibodies for over four years;ARROJO I.P.;Transfusion,2003

2. Very low level viremia in HCV infectious unit missed by NAT;BUSCH M.P.;Transfusion,2003

3. Geographic distribution of hepatitis C virus genotypes in Brazil;CAMPIOTTO S.;Braz. J. med. biol. Res.,2005

4. Development of multiplexed nucleic acid testing for human immunodeficiency virus type 1 and hepatitis C virus;CLELAND A.;Vox Sang,2001

5. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003;COSTE J.;Vox Sang,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3